| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/17/2000 | WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008181A2 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | WO2000008174A1 β-CASEIN EXPRESSING CONSTRUCTS |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008167A1 Trimer of hiv env gene expression product |
| 02/17/2000 | WO2000008165A1 Attenuated equine herpesvirus |
| 02/17/2000 | WO2000008163A2 Aromatic amino acid decarboxylase proteins of a parasitic helminth, nucleic acid molecules coding them, and uses thereof |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008150A1 Method for treatment of invasive cells |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008139A1 Tumor necrosis factor-gamma |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 02/17/2000 | WO2000007624A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 02/17/2000 | WO2000007623A1 Combined vaccine for immunoprophylaxis against viral hepatitis b and d, tetanus, diphtheria and pertussis |
| 02/17/2000 | WO2000007622A1 Attenuated poliovirus vaccine |
| 02/17/2000 | WO2000007621A2 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 02/17/2000 | WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
| 02/17/2000 | WO2000007608A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 02/17/2000 | WO2000007515A1 Improved method for targeted topical treatment of disease |
| 02/17/2000 | WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 02/17/2000 | WO1999062932A3 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES |
| 02/17/2000 | WO1999059500A3 Apparatus and methods for preparing an implantable graft |
| 02/17/2000 | WO1999057289A3 INHIBIN-HBc FUSION PROTEIN |
| 02/17/2000 | WO1999057241A9 Myelin basic protein peptides and uses thereof |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | WO1999054466A3 Colon cancer-associated antigens and their diagnostic and therapeutic uses |
| 02/17/2000 | WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/17/2000 | WO1999045969A3 Radioimmuno-pharmacon for treating the hiv-1 infection |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | WO1998029442A9 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
| 02/17/2000 | CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | CA2347906A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | CA2343163A1 Composition and method of treating disease with extract of musaceas |
| 02/17/2000 | CA2339891A1 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | CA2339486A1 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 02/17/2000 | CA2339413A1 Method for treatment of invasive cells |
| 02/17/2000 | CA2339352A1 N-acetylglycosaminyltransferase genes |
| 02/17/2000 | CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2338020A1 Trimer of hiv env gene expression product |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/16/2000 | EP0979870A1 Human Wnt-6 polypeptide |
| 02/16/2000 | EP0979867A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 02/16/2000 | EP0979648A2 Microspheres of esters of hyaluronic acid for controlled release of an active |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979285A1 Methods to detect granulocytic ehrlichiosis |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein |
| 02/16/2000 | EP0979278A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 02/16/2000 | EP0979275A1 Novel human mago nashi protein |
| 02/16/2000 | EP0979274A2 Human p24 vesicle proteins |
| 02/16/2000 | EP0979246A2 Man monoclonal antibodies to epidermal growth factor receptor |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979225A1 Compounds and compositions for delivering active agents |
| 02/16/2000 | EP0979122A1 Targeted therapy to a biomedical device |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0979100A1 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT |
| 02/16/2000 | EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/16/2000 | EP0561885B1 Subunit papillomavirus vaccine |
| 02/16/2000 | CN1244921A Treatment and diagnosis of cancer |
| 02/16/2000 | CN1244896A Non-M, non-O, HIV-1 strains, fragments and applications |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244871A H. pylori antigens |
| 02/16/2000 | CN1244807A Improved vacines |
| 02/16/2000 | CN1244805A Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 02/16/2000 | CN1244804A Peptide immunotherapeutic agent |
| 02/16/2000 | CN1244583A Preparation and application of native swine vescular disease virus strain and its variant strain |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025470 Provoke proliferation of cytolytic t cells |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025465 Insulin-like growth factor binding protein (IGFBP-6) |
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025342 Analog of Haemophilus Hin47 with reduced protease activity |
| 02/15/2000 | US6025341 Chimeric hepatitis B/hepatitis C virus vaccine |
| 02/15/2000 | US6025204 Diagnostic method for detection of placental-derived prostate growth factors |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025182 Method for producing a virus from an african green monkey kidney cell line |
| 02/15/2000 | US6025181 Equine herpesvirus-4TK mutant |
| 02/15/2000 | US6025180 Asp1 |
| 02/15/2000 | US6025175 Amino acid sequence; for screening new bactericides and bacteristats to treat otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, pleural empyema and endocarditis; diagnosis of infections |
| 02/15/2000 | US6025166 Human trk receptors and neurotrophic factor inhibitors |
| 02/15/2000 | US6025164 Bacterial antigens and vaccine compositions |
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6025130 Nucleotide sequence of gene; for screening of homozygotes, diagnosis, and prenatal screening using oligonucleotide primers |
| 02/15/2000 | US6025125 Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers |
| 02/15/2000 | US6024966 Gene encoding protein antigens of plasmodium falciparum and uses therefor |
| 02/15/2000 | US6024965 Immunology for treatment of aids and t-cell epitopes |
| 02/15/2000 | US6024963 Potentiation of immunogenic response |